Nuvectis Pharma, Inc. Common Stock (NVCT) is a publicly traded Healthcare sector company. As of May 21, 2026, NVCT trades at $10.63 with a market cap of $275.87M and a P/E ratio of -7.99. NVCT moved +3.11% today. Year to date, NVCT is +24.62%; over the trailing twelve months it is -0.19%. Its 52-week range spans $4.44 to $13.34. Analyst consensus is buy with an average price target of $13.50. Rallies surfaces NVCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nuvectis Pharma, Inc. Common Stock (NVCT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NVCT moved +3.11% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $10.63 |
| Market Cap | $275.87M |
| P/E Ratio | -7.99 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.34 |
| 52-Week Low | $4.44 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.44M |
| Gross Margin | 0.00% |
2 analysts cover NVCT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.50.